InflaRx N.V.
IFRX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708688
No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding InflaRx N.V. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Q2 2021 | Change |
|---|---|---|---|
| Holders | 42 | 37 | −5 |
| Shares | 14.5M | 11.2M | −3.29M (−22.8%) |
| Value | $56.4M | $33.1M | −$23.2M (−41.2%) |
New holders (5)
Institutions that held InflaRx N.V. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 197,643 | $587.0K | 0.00% |
| Gsa Capital Partners LLP | 46,633 | $139.0K | 0.02% |
| Marquette Asset Management, LLC | 33,215 | $99.0K | 0.02% |
| IPG Investment Advisors LLC | 25,900 | $76.9K | 0.02% |
| Citadel Advisors LLC | 10,836 | $32.0K | 0.00% |
Sold out (10)
Institutions that held InflaRx N.V. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Sphera Funds Management Ltd. | 1,000,000 | $3.90M |
| CVI Holdings, LLC | 836,881 | $3.26M |
| Granite Point Capital Management, L.P. | 381,086 | $1.49M |
| Eversept Partners, LP | 268,634 | $1.05M |
| Alyeska Investment Group, L.P. | 150,000 | $585.0K |
| Baker Bros. Advisors LP | 138,040 | $538.0K |
| Maven Securities LTD | 110,573 | $431.0K |
| Engineers Gate Manager LP | 13,020 | $51.0K |
| FMR LLC | 6 | $0 |
| Group One Trading, L.P. | 100 | $0 |